Last reviewed · How we verify

NCT06782308

Tinnitus Patient Preferences Survey

Recruiting now Last updated 8 April 2026
What this trial tests

trial testing Survey using a questionnaire. in Tinnitus, Subjective in 500 participants. Currently enrolling.

Timeline
13 January 2025
Primary endpoint
30 October 2026
30 December 2026

Quick facts

Lead sponsorNicolas Gninenko
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date13 January 2025
Primary completion30 October 2026
Estimated completion30 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nicolas Gninenko

Who can join

18 and older, any sex, with Tinnitus, Subjective or Tinnitus, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Survey using a questionnaire.

Trials testing the same drug.

Other recruiting trials for Tinnitus, Subjective

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06782308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing